The street just went mad‑bullish on Singapore banks — RHB is shouting overweight, headlines are cheering 29% wealth fee growth, and Q1 numbers look bulletproof. But if you are an HDB household using dividends to top up CPF and cover Jurong‑to‑Bedok living costs, the only question that matters is: at today’s prices, who is actually paying you enough to justify open‑market risk? In this episode I run DBS, OCBC and UOB through the same forensic yield and capital buffer checklist I use for my own portfolio, and the result is one clean passer, one knife‑edge, and one “not yet” despite a fortress balance sheet. It is a kopitiam‑level breakdown of institutional bank hype versus what lands in your bank account.
Key takeaways:
Why a sector “overweight” call can still fail a 4.7% income hurdle
How DBS, OCBC and UOB rank in my Zone system for retirees
Why OCBC’s fortress balance sheet still gets a Zone 4 Caution today
What UOB’s borderline forward yield means for real‑world bill‑paying
How to separate momentum stories from dependable dividend cheques
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
